CLINICAL_TRIALS
trial_result
· 2023-11-09
Clinical Trial Update: Study of Efficacy, Safety, and Tolerability of LYS006, in Patients With Mild to Moderate Ulcerative Colitis [Phase 2]
Summary
Phase 2 study of LYS006 in mild to moderate ulcerative colitis was terminated; results were posted on 2023-11-09.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Novartis Pharmaceuticals | Conditions: Colitis, Ulcerative | Phase 2 | Status: TERMINATED | Results posted: 2023-11-09